The extracellular chaperone clusterin potently inhibits human lysozyme amyloid formation by interacting with prefibrillar species.
We have studied the effects of the extracellular molecular chaperone, clusterin, on the in vitro aggregation of mutational variants of human lysozyme, including one associated with familial amyloid disease. The aggregation of the amyloidogenic variant I56T is inhibited significantly at clusterin to...
Asıl Yazarlar: | Kumita, JR, Poon, S, Caddy, G, Hagan, C, Dumoulin, M, Yerbury, J, Stewart, E, Robinson, C, Wilson, MR, Dobson, C |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
2007
|
Benzer Materyaller
-
Rationalising lysozyme amyloidosis: insights from the structure and solution dynamics of T70N lysozyme.
Yazar:: Johnson, R, ve diğerleri
Baskı/Yayın Bilgisi: (2005) -
The significance of the location of mutations for the native-state dynamics of human lysozyme
Yazar:: Ahn, M, ve diğerleri
Baskı/Yayın Bilgisi: (2016) -
The extracellular chaperone Clusterin enhances Tau aggregate seeding in a cellular model
Yazar:: Patricia Yuste-Checa, ve diğerleri
Baskı/Yayın Bilgisi: (2021-08-01) -
The Extracellular Molecular Chaperone Clusterin Inhibits Amyloid Fibril Formation and Suppresses Cytotoxicity Associated with Semen-Derived Enhancer of Virus Infection (SEVI)
Yazar:: Abigail K. Elias, ve diğerleri
Baskı/Yayın Bilgisi: (2022-10-01) -
Expression and purification of chaperone-active recombinant clusterin.
Yazar:: Rebecca A Dabbs, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)